Shinemax Pharma India Pvt Ltd
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Vogmax GM 1mg/500mg/0.2mg Tablet is a combination of medicines used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet
Vogmax GM 1mg/500mg/0.2mg Tablet belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Vogmax GM 1mg/500mg/0.2mg Tablet is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Vogmax GM 1mg/500mg/0.2mg Tablet.
Vogmax GM 1mg/500mg/0.2mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Vogmax GM 1mg/500mg/0.2mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Vogmax GM 1mg/500mg/0.2mg Tablet is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines alcohol or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain loss of appetite or yellowing of the eyes or skin (jaundice).
Vogmax GM 1mg/500mg/0.2mg Tablet contains a combination of three medications: Glimepiride, Metformin, and Voglibose. This medication is used to manage type 2 diabetes mellitus (DM). It helps regulate blood glucose levels in adults when taken with proper diet and regular exercise. Glimepiride promotes insulin release from the pancreas, metformin reduces glucose production by the liver, and Voglibose inhibits alpha-glucosidase, leading to lower postprandial (after meal) glucose levels. This combination is not indicated for the treatment of type 1 diabetes.
Common side effects associated with Vogmax GM 1mg/500mg/0.2mg Tablet include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection.
This medication is contraindicated for patients with known allergies to any component of the drug or its excipients. It is also not recommended for patients with moderate to severe kidney disease, inflammatory bowel disease (IBD), colonic ulcers, or underlying metabolic acidosis including diabetic ketoacidosis.
No, consuming alcohol with Vogmax GM 1mg/500mg/0.2mg Tablet is not advised. It may exacerbate hypoglycemia and increase the risk of lactic acidosis.
Yes, using this medication can lead to hypoglycemia (low blood sugar). Symptoms of hypoglycemia include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. This is more likely if you miss meals, drink alcohol, exercise excessively, or take other antidiabetic medications simultaneously.
Store this medication in its original container with the seal intact, at room temperature. Dispose of unused medication appropriately. Keep this medication out of reach of children, pets, and other individuals.